Douglas Roblin to Drug Monitoring
This is a "connection" page, showing publications Douglas Roblin has written about Drug Monitoring.
Connection Strength
0.220
-
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med. 2010 Apr; 25(4):326-33.
Score: 0.090
-
Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother. 2007 Feb; 41(2):193-200.
Score: 0.073
-
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf. 2010 Jan; 19(1):19-25.
Score: 0.022
-
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):55-64.
Score: 0.018
-
Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006 Oct; 65(10):1368-72.
Score: 0.017